SKI Market

A+| A| A-|

Indian Indices

Sensex

78,674.51 180.97
( 0.23%)

Global Indices

Nasdaq

49,467.44 867.71
(1.79%)

Dow Jones

7,146.92 84.64
(1.20%)

Hang Seng

58,837.37 -680.97
(-1.14%)

Nikkei 225

10,660.47 70.48
(0.67%)

Forex

USD-INR

93.19 -0.12
(-0.13%)

EUR-INR

109.85 -0.18
(-0.16%)

GBP-INR

126.25 -0.31
(-0.25%)

JPY-INR

0.59 0.00
(-0.15%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

IRB InvIT Fund

Industry : Construction

BSE Code

ISIN Demat

Book Value()

540526

INE183W23014

102.844126

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

IRBINVIT

9.93

4859.59

EPS(TTM)

Face Value()

Div & Yield %

6.19

102

9.56

Back

ruby mills ltd

Dr Reddy's Laboratories consolidated net profit declines 14.42% in the December 2025 quarter

Jan 21,2026

Net profit of Dr Reddy's Laboratories declined 14.42% to Rs 1209.90 crore in the quarter ended December 2025 as against Rs 1413.70 crore during the previous quarter ended December 2024. Sales rose 4.41% to Rs 8727.00 crore in the quarter ended December 2025 as against Rs 8358.60 crore during the previous quarter ended December 2024.

Particulars	Quarter Ended
	Dec. 2025	Dec. 2024	% Var.
Sales	8727.00	8358.60	4
OPM %	21.63	27.19	-
PBDT	2064.20	2345.70	-12
PBT	1543.20	1874.30	-18
NP	1209.90	1413.70	-14

78,674.51 180.97 ( 0.23%)

49,467.44 867.71 (1.79%)

7,146.92 84.64 (1.20%)

58,837.37 -680.97 (-1.14%)

10,660.47 70.48 (0.67%)

93.19 -0.12 (-0.13%)

109.85 -0.18 (-0.16%)

126.25 -0.31 (-0.25%)

0.59 0.00 (-0.15%)